Archive for July 2022
Real-world data used to combat COVID-19
Monitoring data on hospitals’ utilisation and capacity rates: location and number of licensed beds, staffed beds, ICU beds, and total bed utilisation rates Plan for critical care based on epidemiological data on COVID-19 and clinical outcomes: modeling tools development to identify surges in clinical demand, as well as best- and worst-case scenarios of COVID-19-induced strain on…
Read MoreDISTILL by SVMPharma designed and developed by researchers for clinical research organisations
DISTILL is designed from the ground up to allow sponsors to self-configure and run clinical trials, however at SVMPharma our product specialists are ready to assist at any stage. Our agile approach ensures rapid, fully tested trial setup and in-study changes. Combined with DISTILL’s low-code, no-code platform, we are able to offer quicker user acceptance…
Read MoreUse of real-world evidence to create standardised treatment pathways is essential for the future of oncology
“A truly high-value drug is the one that costs the least and has the most benefit for our patients” “What we need is more research focusing on value-based pricing, rigorous post-approval follow-up for efficacy and toxicity, and use of real world evidence in the creation of standardized treatment pathways.” Devika Das, MBBS, Clinical Assistant Professor…
Read MoreWhy was DISTILL built on Low-Code, No-Code?
DISTILL is designed from the ground up to allow sponsors to self-configure and run clinical trials, however at SVMPharma our product specialists are ready to assist at any stage. Our agile approach ensures rapid, fully tested trial setup and in-study changes. Combined with DISTILL’s low-code, no-code platform, we are able to offer quicker user acceptance…
Read MoreUnique therapeutic options matched to patient characteristics identified by real-world evidence (RWE)
Interest and use of RWE in the pharmaceutical industry is expected to increase in the coming year, due to its role in regulatory approvals However, studies have shown that accuracy levels of electronic data can be as vary from as low as 30% to as high as 90% Where data is inaccurate, data enrichment will…
Read MoreDISTILL designed and developed by researchers for your clinical trials
DISTILL is designed from the ground up to allow sponsors to self-configure and run clinical trials, however at SVMPharma our product specialists are ready to assist at any stage. Our agile approach ensures rapid, fully tested trial setup and in-study changes. Combined with DISTILL’s low-code, no-code platform, we are able to offer quicker user acceptance…
Read MoreFDA turned to real-world evidence in the fight against COVID-19
“Within the context of COVID-19, we’ve got this urgency to learn what we can as soon as we can, and that means that we need to be learning from the patients that are receiving care right now and trying to understand how do we apply that as quickly as possible” Utilising RWD sources such as…
Read MoreSVMPharma launch DISTILL a new electronic data capture system
DISTILL is designed from the ground up to allow sponsors to self-configure and run clinical trials, however at SVMPharma our product specialists are ready to assist at any stage. Our agile approach ensures rapid, fully tested trial setup and in-study changes. Combined with DISTILL’s low-code, no-code platform, we are able to offer quicker user acceptance…
Read MoreBaseline UK real-world study in ovarian cancer pre-PARPi published
A study was published recently on the real-world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors as a result of a collaboration between AstraZeneca and SVMPharma The study, aside from providing a baseline for future evaluations to…
Read MoreWhy was DISTILL built on Low-Code, No-Code?
DISTILL is designed from the ground up to allow sponsors to self-configure and run clinical trials, however at SVMPharma our product specialists are ready to assist at any stage. Our agile approach ensures rapid, fully tested trial setup and in-study changes. Combined with DISTILL’s low-code, no-code platform, we are able to offer quicker user acceptance…
Read More